Anand B. Karnad
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 0/1 Biomarker and Pharmacodynamic Study of Roflumilast in Patients With Advanced B-Cell Hematologic Malignancies (CTRC# 13-0013) (NCT01888952) | Anand B. Karnad | 2013-07-01 |
Track Anand B. Karnad automatically
Every clearance here is in the API, with alerts when new ones post.